Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control

Area of Science:

• Virology
• Molecular Biology
• Public Health

Background:

• Alphaviruses are globally distributed arboviruses infecting diverse hosts and causing significant human morbidity and mortality.
• Despite their importance, no effective antiviral drugs currently exist for alphavirus infections.
• The EU-supported VIZIER project aimed to develop antiviral therapies for RNA viruses, including alphaviruses.

Purpose of the Study:

• To review major features of alphaviruses investigated in recent years.
• To highlight progress in understanding alphavirus replicative enzyme structure and function.
• To discuss the development of new disease control strategies for alphavirus infections.

Main Methods:

• Review of existing literature on alphavirus classification, epidemiology, and evolutionary history.
• Analysis of research findings from the VIZIER project on alphavirus enzyme structure and function.
• Examination of emerging disease control strategies for alphaviruses.

Main Results:

• Alphaviruses exhibit expanding geographic distribution, exemplified by Chikungunya virus.
• Significant progress has been made in understanding the structure and function of alphavirus replicative enzymes.
• New strategies for controlling alphavirus-induced diseases are being developed.

Conclusions:

• Continued research into alphavirus biology is crucial for developing effective antiviral treatments.
• Structural genomics and functional studies of viral enzymes are key to drug discovery.
• Integrated approaches combining epidemiological surveillance and therapeutic development are needed to combat alphavirus threats.